Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Jul 8

PMID 27384772

Citations 5

Authors

Liling Huang

Cunxu Liu

Yan Deng

Yanqiong Liu

Jiangyang Zhao

Xiuli Huang

Wenjun Tang

Yifan Sun

Xue Qin

Shan Li

Affiliations

Soon will be listed here.

Abstract

Objective: Hypoxia-inducible factor-2 alpha (HIF-2a) plays a major role in the progression of disease, although the role of HIF-2α gene polymorphisms in hepatitis B virus (HBV)-related diseases remains elusive. The aim of this study is to determine whether HIF-2a rs13419896 and rs6715787 single-nucleotide polymorphisms (SNPs) are associated with susceptibility to chronic hepatitis B (CHB), liver cirrhosis (LC), or hepatocellular carcinoma (HCC).

Method: A case-control study of 107 patients with CHB, 83 patients with LC, 234 patients with HCC, and 224 healthy control subjects was carried out, and the HIF-2a rs13419896 and rs6715787 SNPs were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results: No significant differences were observed in the genotype or allele frequency of two HIF-2a SNPs between the cases and controls (all p>0.05). However, in subgroup analysis by gender, the HIF-2a rs13419896 GA and AA genotypes were significantly associated with a risk of CHB (odds ratio [OR] = 3.565, 95% confidence interval [CI] = 1.123-11.314, p = 0.031 and OR = 12.506, 95% CI = 1.329-117.716, p = 0.027) in females, and the A allele of rs13419896 was associated with a risk of CHB (OR = 2.624, 95% CI = 1.244-5.537, p = 0.011) and LC (OR = 2.351, 95% CI = 1.002-5.518, p = 0.050) in females. The rs6715787 CG genotype polymorphism may contribute to a reduced risk of LC in the Guangxi Zhuang Chinese population (OR = 0.152, 95% CI = 0.028-0.807, p = 0.027), as determined via subgroup analysis by ethnicity. Moreover, binary logistic regression analyses that were adjusted by drinking status indicated that the AA genotype of rs13419896 may contribute to an increased risk of LC in the non-alcohol-drinking population (OR = 3.124, 95% CI = 1.091-8.947, p = 0.034). In haplotype analysis, GG haplotype was significantly associated with a reduced risk of LC (OR = 0.601, 95% CI = 0.419-0.862, p = 0.005).

Conclusions: The HIF-2a rs13419896 polymorphism is associated with an increased risk of CHB and LC in the Guangxi Chinese population, especially in females and in the non-alcohol-drinking population, while the HIF-2a gene rs6715787 polymorphism is associated with a decreased risk of LC in the Guangxi Zhuang population.

Citing Articles

The role of polymorphisms on COPD susceptibility in southern Chinese.

Wang Y, Lin A, He R, Chen C, Zeng X, Pan Y Heliyon. 2023; 9(10):e20226.

PMID: 37876439 PMC: 10590761. DOI: 10.1016/j.heliyon.2023.e20226.

Loss of Heterozygosity for Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism.

Ma Y, Ling S, Li Y, Hu M, Kong B, Huang P Int J Mol Sci. 2022; 23(12).

PMID: 35743139 PMC: 9224498. DOI: 10.3390/ijms23126697.

Oxygen Sensing and Viral Replication: Implications for Tropism and Pathogenesis.

Liu P, Balfe P, McKeating J, Schilling M Viruses. 2020; 12(11).

PMID: 33113858 PMC: 7693908. DOI: 10.3390/v12111213.

The role of IL22 polymorphisms on liver cirrhosis in patients with hepatitis B virus: A case control study.

Gao Y, Li Q, Wang C, Sun J, Wang X, Li Y Medicine (Baltimore). 2019; 98(44):e17867.

PMID: 31689880 PMC: 6946515. DOI: 10.1097/MD.0000000000017867.

Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma.

Xu T, Zhu A, Sun M, Lv J, Qian Z, Wang X Oncotarget. 2018; 9(1):96-109.

PMID: 29416599 PMC: 5787527. DOI: 10.18632/oncotarget.22941.

References

Purdue M, Johansson M, Zelenika D, Toro J, Scelo G, Moore L . Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 2010; 43(1):60-5. PMC: 3049257. DOI: 10.1038/ng.723. View

Nizet V, Johnson R . Interdependence of hypoxic and innate immune responses. Nat Rev Immunol. 2009; 9(9):609-17. PMC: 4343208. DOI: 10.1038/nri2607. View

Bhandari T, Nizet V . Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases. Infect Dis Ther. 2014; 3(2):159-74. PMC: 4269623. DOI: 10.1007/s40121-014-0030-1. View

Harkisoen S, Arends J, van Erpecum K, van den Hoek A, Hoepelman A . Hepatitis B viral load and risk of HBV-related liver disease: from East to West?. Ann Hepatol. 2012; 11(2):164-71. View

Lu Y, Sui J, Liu Y, Li R, Ma L, Zhang X . Association between hypoxia-inducible factor-1α gene polymorphisms and risk of chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: a retrospective case-control study. Gene. 2015; 564(1):96-100. DOI: 10.1016/j.gene.2015.03.053. View

Erler J, Bennewith K, Nicolau M, Dornhofer N, Kong C, Le Q . Lysyl oxidase is essential for hypoxia-induced metastasis. Nature. 2006; 440(7088):1222-6. DOI: 10.1038/nature04695. View

Rohwer N, Cramer T . Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat. 2011; 14(3):191-201. DOI: 10.1016/j.drup.2011.03.001. View

Giatromanolaki A, Koukourakis M, Sivridis E, Turley H, Talks K, Pezzella F . Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer. 2001; 85(6):881-90. PMC: 2375073. DOI: 10.1054/bjoc.2001.2018. View

Bosch F, Ribes J, Diaz M, Cleries R . Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004; 127(5 Suppl 1):S5-S16. DOI: 10.1053/j.gastro.2004.09.011. View

10.

Gong L, Zhang W, Zhou J, Lu J, Xiong H, Shi X . Prognostic value of HIFs expression in head and neck cancer: a systematic review. PLoS One. 2013; 8(9):e75094. PMC: 3772872. DOI: 10.1371/journal.pone.0075094. View

11.

Sang N, Stiehl D, Bohensky J, Leshchinsky I, Srinivas V, Caro J . MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem. 2003; 278(16):14013-9. PMC: 4518846. DOI: 10.1074/jbc.M209702200. View

12.

Te H, Jensen D . Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010; 14(1):1-21, vii. DOI: 10.1016/j.cld.2009.11.009. View

13.

Gustafsson M, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J . Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005; 9(5):617-28. DOI: 10.1016/j.devcel.2005.09.010. View

14.

Loboda A, Jozkowicz A, Dulak J . HIF-1 and HIF-2 transcription factors--similar but not identical. Mol Cells. 2010; 29(5):435-42. DOI: 10.1007/s10059-010-0067-2. View

15.

Holmquist L, Lofstedt T, Pahlman S . Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models. Adv Exp Med Biol. 2006; 587:179-93. DOI: 10.1007/978-1-4020-5133-3_16. View

16.

Karapetsas A, Giannakakis A, Pavlaki M, Panayiotidis M, Sandaltzopoulos R, Galanis A . Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α. Int J Biochem Cell Biol. 2011; 43(11):1582-90. DOI: 10.1016/j.biocel.2011.07.007. View

17.

Arias-Loste M, Fabrega E, Lopez-Hoyos M, Crespo J . The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease. Biomed Res Int. 2015; 2015:319745. PMC: 4600870. DOI: 10.1155/2015/319745. View

18.

Morgan T, Mandayam S, Jamal M . Alcohol and hepatocellular carcinoma. Gastroenterology. 2004; 127(5 Suppl 1):S87-96. DOI: 10.1053/j.gastro.2004.09.020. View

19.

OROURKE J, Tian Y, Ratcliffe P, Pugh C . Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha. J Biol Chem. 1999; 274(4):2060-71. DOI: 10.1074/jbc.274.4.2060. View

20.

Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin Jr W . Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell. 2002; 1(3):237-46. DOI: 10.1016/s1535-6108(02)00043-0. View